NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 53 filers reported holding NEXTCURE INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,592 | -66.8% | 39,994 | -53.7% | 0.00% | – |
| Q2 2023 | $155,486 | +154.9% | 86,381 | +109.6% | 0.00% | – |
| Q1 2023 | $60,995 | -9.8% | 41,213 | -14.1% | 0.00% | – |
| Q4 2022 | $67,619 | -56.4% | 47,957 | -14.7% | 0.00% | – |
| Q3 2022 | $155,000 | -86.0% | 56,200 | -76.2% | 0.00% | – |
| Q2 2022 | $1,110,000 | +9.4% | 236,300 | +13.2% | 0.00% | – |
| Q1 2022 | $1,015,000 | -60.7% | 208,712 | -51.5% | 0.00% | – |
| Q4 2021 | $2,582,000 | +109.7% | 430,430 | +135.8% | 0.00% | – |
| Q3 2021 | $1,231,000 | -52.6% | 182,507 | -43.6% | 0.00% | – |
| Q2 2021 | $2,598,000 | +1.3% | 323,500 | +26.3% | 0.00% | – |
| Q1 2021 | $2,564,000 | -48.3% | 256,100 | -43.7% | 0.00% | – |
| Q4 2020 | $4,962,000 | +200.2% | 455,200 | +142.4% | 0.00% | – |
| Q3 2020 | $1,653,000 | +15.8% | 187,800 | +182.1% | 0.00% | – |
| Q2 2020 | $1,427,000 | +85.8% | 66,565 | +221.3% | 0.00% | – |
| Q1 2020 | $768,000 | -34.0% | 20,718 | +0.3% | 0.00% | – |
| Q4 2019 | $1,164,000 | – | 20,663 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,671,856 | $16,031,000 | 0.94% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 193,012 | $1,158,000 | 0.47% |
| DAFNA Capital Management LLC | 187,696 | $1,126,000 | 0.28% |
| Sio Capital Management, LLC | 130,000 | $780,000 | 0.24% |
| Orbimed Advisors | 2,711,013 | $16,266,000 | 0.21% |
| Long Focus Capital Management, LLC | 225,000 | $1,350,000 | 0.18% |
| Lombard Odier Asset Management (Switzerland) SA | 407,291 | $2,444,000 | 0.16% |
| Ikarian Capital, LLC | 134,055 | $804,000 | 0.12% |
| Minerva Advisors LLC | 31,713 | $190,000 | 0.11% |
| Anson Funds Management LP | 115,328 | $692,000 | 0.07% |